Market Overview

IntriCon Announces Proposed Public Offering of 1,500,000 Shares of Common Stock

Share:

IntriCon Corporation (NASDAQ:IIN), a designer, developer,
manufacturer and distributor of body-worn devices, today announced that
it intends to offer and sell 1,500,000 shares of its common stock in an
underwritten public offering. IntriCon also expects to grant to the
underwriters for the offering a 30-day option to purchase an additional
225,000 shares of common stock. All of the shares to be sold in the
offering are to be sold by IntriCon. IntriCon intends to use the net
proceeds from the offering to repay debt, to fund capital expenditures,
to repurchase and retire 500,000 shares of its common stock from certain
of its directors and officers at a price equal to the net proceeds per
share that IntriCon will receive from the offering, before expenses, and
for working capital and other general corporate purposes. The offering
is subject to market conditions, and there can be no assurance as to
whether or when the offering may be completed, or as to the actual size
or terms of the offering.

Stifel is acting as sole book-running manager of the proposed offering.

A shelf registration statement on Form S-3 relating to the public
offering of the shares of common stock described above was filed with
the Securities and Exchange Commission (the "SEC") and is effective. A
preliminary prospectus supplement relating to the offering has been
filed with the SEC. Copies of the preliminary prospectus supplement and
accompanying base prospectus may be obtained from Stifel, Nicolaus &
Company, Incorporated, Attention: Syndicate, One Montgomery Street,
Suite 3700, San Francisco, California 94104, by telephone at (415)
364-2720 or by email at syndprospectus@stifel.com.
Electronic copies of the preliminary prospectus supplement and
accompanying base prospectus are also available on the website of the
SEC at http://www.sec.gov.

This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the shares described herein or any other
securities, nor shall there be any sale of these securities in any state
or other jurisdiction in which such offer, solicitation or sale would be
unlawful prior to the registration or qualification under the securities
laws of any such state or other jurisdiction. The offering may be made
only by means of a prospectus supplement and the accompanying base
prospectus.

About IntriCon Corporation

Headquartered in Arden Hills, Minn., IntriCon Corporation designs,
develops and manufactures miniature and micro-miniature body-worn
devices. These advanced products help medical, healthcare and
professional communications companies meet the rising demand for
smaller, more intelligent and better-connected devices. IntriCon has
facilities in the United States, Asia, the United Kingdom and Europe.
The company's common stock trades under the symbol "IIN" on the Nasdaq
Global Market. For more information about IntriCon, visit www.intricon.com.

Forward-Looking Statements

Statements made in this release and in IntriCon's other public filings
and releases that are not historical facts or that include
forward-looking terminology, including expectations on the completion,
timing and size of the proposed public offering and the anticipated use
of proceeds therefrom, are "forward-looking statements" within the
meaning of the Securities Exchange Act of 1934, as amended. These
forward-looking statements may be affected by known and unknown risks,
uncertainties and other factors that are beyond IntriCon's control,
including the risks and uncertainties associated with market conditions
and the satisfaction of customary closing conditions related to the
proposed public offering, as well as risks and uncertainties inherent in
IntriCon's business, and may cause IntriCon's actual results,
performance or achievements to differ materially from the results,
performance and achievements expressed or implied in the forward-looking
statements. These risks, uncertainties and other factors are detailed
from time to time in the company's filings with the Securities and
Exchange Commission, including the Annual Report on Form 10-K for the
year ended December 31, 2017, and in the preliminary prospectus
supplement related to the proposed offering, each available on the SEC's
web site at www.sec.gov.
The company disclaims any intent or obligation to publicly update or
revise any forward-looking statements, regardless of whether new
information becomes available, future developments occur or otherwise.

View Comments and Join the Discussion!